Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Wager: A concern that drug companies cannot ignore. (0.08 sec) 

A concern that drug companies cannot ignore


E Wager - JRSM, 2005 - jrsm.rsmjournals.com
A report by the House of Commons Health Committee into the influence of the UK
pharmaceutical industry has recommended that companies should publish the
results of all their trials and follow guidelines for responsible ...
Cited by 1 - Related articles - BL Direct - All 7 versions

Medical editors issue guidance on ghost writing


L Eaton - British Medical Journal, 2005 - bmj.com
You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... The World Association of ...
Cited by 8 - Related articles - All 5 versions

The involvement of professional medical writers in medical publications


SS Daskalopoulou, DP Mikhailidis - Current Medical Research and Opinion®, 2005 - informahealthcare.com
Page 1. CURRENT MEDICAL RESEARCH AND OPINION® VOL. 21, NO. 2, 2005, 307–309 ©
2005 LIBRAPHARM LIMITED 0300-7995 doi:10.1185/030079905X28944 ...
Cited by 4 - Related articles - All 8 versions

Scientific discourse, corporate ghostwriting, journal policy, and public trust

- nih.gov
WM Tierney, MS Gerrity - Journal of General Internal Medicine, 2005 - Springer
Advancements in science, clinical care, and medical edu- cation require a
discourse among basic and clinical scientists, clinicians, and medical
educators. Peer-reviewed journals such as Journal of General Internal ...
Cited by 6 - Related articles - All 6 versions

Time for the ghosts to take on physical form


A Jacobs - The Lancet, 2004 - Elsevier
In April this year, the World Association of Medical Editors (WAME) published a
set of guidelines 1 on publication ethics for medical journals. These guidelines
cover many aspects of publication ethics, including study design, ...
Cited by 6 - Related articles - All 4 versions

[CITATION] for the AMWA 2002 Task Force on the Contributions of Medical Writers to Scientific …


CW Hamilton, MG Royer - AMWA Journal, 2003
Cited by 8 - Related articles

“Good Publication Practice for Pharmaceutical Companies”: Where Are We Now?


E Wager - Medscape General Medicine, 2005 - pubmedcentral.nih.gov
Disclosure: Elizabeth Wager, MA, has disclosed the contribution of all members
of the GPP Working Group (past and present) in developing the guidelines. This
article represents Ms. Wager's personal opinion rather than that of the ...
Cited by 4 - Related articles - All 5 versions

[PDF] Trial registration: What do writers need to know


E Wager - The Write Stuff, 2006 - emwa.org
Trial registration: the current situation The International Committee of Medical
Journal Editors (ICMJE), which comprises the editors of some of the world's most
influential medical journals, have added an extra hurdle for publication. ...
Cited by 1 - Related articles - View as HTML - All 3 versions

Uniform clinical trial registration policy for journals of kidney diseases, dialysis, and …


WG Couser, T Drueke, P Halloran, B Kasiske, … - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol
Medical research can be seriously compromised by the selective publication of
clinical trial results. Therefore, it is imperative that information re- garding
clinical trials be available to the general public. We require, as a ...
Cited by 9 - Related articles - All 15 versions

[CITATION] Findings from the 2004 AMWA salary survey


T Gray, CW Hamilton - AMWA Journal, 2004
Cited by 3 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google